Monoclonal Anti-Belantamab Antibody, Mouse IgG1 (13D8)

1/1
製品番号/仕様
価格
Availability
数量
BEB-MY2503-100ug
$355.00
In Stock - Delivery in 2-3 business days
BEB-MY2503-1mg (500ug X 2)
$2,695.00
In Stock - Delivery in 2 weeks
BEB-MY2503
製品金額 :
$ 0
推奨新製品 Request Quote
Contact Us
Contact Us
製品金額:
$ 0
  • 製品詳細
  • データ表示
  • Reviews & Citations
  • Important Statement
  • Resources
Source

Chimeric Monoclonal Anti-Belantamab Antibody, Mouse IgG1 (13D8) is recombinantly expressed in HEK293. It consists of mouse variable regions genetically fused to mouse IgG1 constant domains.

Antibody Type

Recombinant Monoclonal

Clone

13D8

Isotype

Mouse IgG1, Kappa

Host Species

Mouse

Specificity

Specifically recognizes Human Belantamab; This antibody is a neutralizing antibody.

Application
Application
Recommended Use / Performance
ELISA
0.2-2 μg/mL
Purification

Protein A purified.

Aggregation

Less than 5%, as determined by SEC-MALS.

Concentration

Please refer to the Certificate of Analysis (CoA).

Form

Lyophilized

Formulation

Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.

Please contact us for customized product forms or formulations.

Reconstitution

Please refer to the Certificate of Analysis (CoA) for specific instructions.

Shipping

Lyophilized product is shipped at ambient temperature.

Storage

For long term storage, the product should be stored in a lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • -20°C to -70°C for 12 months in lyophilized state;
  • -70°C for 3 months under sterile conditions after reconstitution.
Notices

Product Specific Notices: For research use only.

バックグランド

Belantamab is a B-cell maturation antigen (BCMA) binding humanized monoclonal antibody. Belantamab is composed of the Fv (variable; antigen-binding) regions of the CA8 murine BCMA monoclonal antibody specific for the extracellular domain of human BCMA with human IgG1 heavy and kappa light chain constant (framework) regions.